Clinical Trial Update: Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Docetaxel & Cisplatin with LDFRT to Docetaxel & Cisplatin in locally advanced nasopharyngeal cancer is in early stages with unknown stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• LDFRT (low-dose fractionated radiotherapy)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Nasopharyngeal Cancer | Phase 2 | Status: UNKNOWN